1. Home
  2. VERU vs KOSS Comparison

VERU vs KOSS Comparison

Compare VERU & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • KOSS
  • Stock Information
  • Founded
  • VERU 1971
  • KOSS 1953
  • Country
  • VERU United States
  • KOSS United States
  • Employees
  • VERU N/A
  • KOSS N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • KOSS Consumer Electronics/Appliances
  • Sector
  • VERU Health Care
  • KOSS Consumer Staples
  • Exchange
  • VERU Nasdaq
  • KOSS Nasdaq
  • Market Cap
  • VERU 54.6M
  • KOSS 49.1M
  • IPO Year
  • VERU 1990
  • KOSS N/A
  • Fundamental
  • Price
  • VERU $2.88
  • KOSS $4.87
  • Analyst Decision
  • VERU Strong Buy
  • KOSS
  • Analyst Count
  • VERU 3
  • KOSS 0
  • Target Price
  • VERU $33.33
  • KOSS N/A
  • AVG Volume (30 Days)
  • VERU 182.9K
  • KOSS 57.4K
  • Earning Date
  • VERU 12-15-2025
  • KOSS 10-30-2025
  • Dividend Yield
  • VERU N/A
  • KOSS N/A
  • EPS Growth
  • VERU N/A
  • KOSS N/A
  • EPS
  • VERU N/A
  • KOSS N/A
  • Revenue
  • VERU $16,886,419.00
  • KOSS $12,624,170.00
  • Revenue This Year
  • VERU N/A
  • KOSS N/A
  • Revenue Next Year
  • VERU N/A
  • KOSS N/A
  • P/E Ratio
  • VERU N/A
  • KOSS N/A
  • Revenue Growth
  • VERU 337.24
  • KOSS 2.93
  • 52 Week Low
  • VERU $2.64
  • KOSS $4.00
  • 52 Week High
  • VERU $14.20
  • KOSS $8.59
  • Technical
  • Relative Strength Index (RSI)
  • VERU 32.50
  • KOSS 43.27
  • Support Level
  • VERU $2.76
  • KOSS $4.75
  • Resistance Level
  • VERU $3.99
  • KOSS $5.30
  • Average True Range (ATR)
  • VERU 0.29
  • KOSS 0.32
  • MACD
  • VERU -0.17
  • KOSS -0.00
  • Stochastic Oscillator
  • VERU 11.23
  • KOSS 17.86

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.

Share on Social Networks: